Name | Description | Patent Applicant | Current Assignee | Inventor | Patent Jurisdiction | Patent Number | Date of Patent | ||
---|---|---|---|---|---|---|---|---|---|
Patent 6889690 was granted and assigned to Oriel Therapeutics on May, 2005 by the United States Patent and Trademark Office. | 6889690 | May 10, 2005 | |||||||
Patent 8365725 was granted and assigned to Oriel Therapeutics on February, 2013 by the United States Patent and Trademark Office. | 8365725 | February 5, 2013 | |||||||
Patent 7624733 was granted and assigned to Oriel Therapeutics on December, 2009 by the United States Patent and Trademark Office. | 7624733 | December 1, 2009 | |||||||
Patent 8210172 was granted and assigned to Oriel Therapeutics on July, 2012 by the United States Patent and Trademark Office. | 8210172 | July 3, 2012 | |||||||
Patent 9339616 was granted and assigned to Oriel Therapeutics on May, 2016 by the United States Patent and Trademark Office. | 9339616 | May 17, 2016 | |||||||
Patent 7520278 was granted and assigned to Oriel Therapeutics on April, 2009 by the United States Patent and Trademark Office. | 7520278 | April 21, 2009 | |||||||
Patent 7428446 was granted and assigned to Oriel Therapeutics on September, 2008 by the United States Patent and Trademark Office. | 7428446 | September 23, 2008 | |||||||
Patent 8210171 was granted and assigned to Oriel Therapeutics on July, 2012 by the United States Patent and Trademark Office. | 8210171 | July 3, 2012 | |||||||
Patent 7377277 was granted and assigned to Oriel Therapeutics on May, 2008 by the United States Patent and Trademark Office. | 7377277 | May 27, 2008 | |||||||
Patent 8671938 was granted and assigned to Oriel Therapeutics on March, 2014 by the United States Patent and Trademark Office. | 8671938 | March 18, 2014 | |||||||
Patent 8985103 was granted and assigned to Oriel Therapeutics on March, 2015 by the United States Patent and Trademark Office. | 8985103 | March 24, 2015 | |||||||
Patent 9597465 was granted and assigned to Oriel Therapeutics on March, 2017 by the United States Patent and Trademark Office. | 9597465 | March 21, 2017 | |||||||
Patent 9795749 was granted and assigned to Oriel Therapeutics on October, 2017 by the United States Patent and Trademark Office. | 9795749 | October 24, 2017 | |||||||
Patent 9027551 was granted and assigned to Oriel Therapeutics on May, 2015 by the United States Patent and Trademark Office. | 9027551 | May 12, 2015 | |||||||
Patent D685461 was granted and assigned to Oriel Therapeutics on July, 2013 by the United States Patent and Trademark Office. | D685461 | July 2, 2013 | |||||||
Patent 8646446 was granted and assigned to Oriel Therapeutics on February, 2014 by the United States Patent and Trademark Office. | 8646446 | February 11, 2014 | |||||||
Patent 8991391 was granted and assigned to Oriel Therapeutics on March, 2015 by the United States Patent and Trademark Office. | 8991391 | March 31, 2015 | |||||||
Patent 8375941 was granted and assigned to Oriel Therapeutics on February, 2013 by the United States Patent and Trademark Office. | 8375941 | February 19, 2013 | |||||||
Patent 9050427 was granted and assigned to Oriel Therapeutics on June, 2015 by the United States Patent and Trademark Office. | 9050427 | June 9, 2015 | |||||||
Patent 9278767 was granted and assigned to Oriel Therapeutics on March, 2016 by the United States Patent and Trademark Office. | 9278767 | March 8, 2016 | |||||||
Patent 7677411 was granted and assigned to Oriel Therapeutics on March, 2010 by the United States Patent and Trademark Office. | 7677411 | March 16, 2010 | |||||||
Patent 9889953 was granted and assigned to Oriel Therapeutics on February, 2018 by the United States Patent and Trademark Office. | 9889953 | February 13, 2018 | |||||||
Patent 8720497 was granted and assigned to Oriel Therapeutics on May, 2014 by the United States Patent and Trademark Office. | 8720497 | May 13, 2014 | |||||||
Patent 8327843 was granted and assigned to Oriel Therapeutics on December, 2012 by the United States Patent and Trademark Office. | 8327843 | December 11, 2012 | |||||||
Patent D711528 was granted and assigned to Oriel Therapeutics on August, 2014 by the United States Patent and Trademark Office. | D711528 | August 19, 2014 |